Cargando…
Aggressive local therapy for de novo metastatic breast cancer: Challenges and updates (Review)
Systemic therapy has been viewed as the mainstay for de novo metastatic breast cancer (dnMBC). However, as dnMBC is highly heterogeneous both biologically and clinically, and with ever-improving systemic strategies, it has been implied that the local therapy of the primary tumor (PT) may be benefici...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394734/ https://www.ncbi.nlm.nih.gov/pubmed/37449542 http://dx.doi.org/10.3892/or.2023.8600 |